Outlook Wealth Advisors LLC Grows Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Outlook Wealth Advisors LLC boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 437 shares of the medical equipment provider’s stock after buying an additional 29 shares during the quarter. Outlook Wealth Advisors LLC’s holdings in Intuitive Surgical were worth $228,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Godsey & Gibb Inc. lifted its holdings in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new position in shares of Intuitive Surgical during the third quarter valued at $33,000. Capital Performance Advisors LLP bought a new stake in shares of Intuitive Surgical during the 3rd quarter worth about $38,000. DT Investment Partners LLC raised its holdings in Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after purchasing an additional 36 shares in the last quarter. Finally, Mark Sheptoff Financial Planning LLC acquired a new stake in shares of Intuitive Surgical in the second quarter valued at $37,000. 83.64% of the stock is currently owned by institutional investors.

Insider Activity at Intuitive Surgical

In other news, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Mark Brosius sold 2,128 shares of the company’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the sale, the senior vice president now directly owns 273 shares in the company, valued at $140,595. This trade represents a 88.63 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 48,190 shares of company stock worth $25,012,927. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $584.08 on Friday. The stock has a 50 day simple moving average of $538.34 and a 200 day simple moving average of $497.08. Intuitive Surgical, Inc. has a 52-week low of $355.17 and a 52-week high of $585.50. The firm has a market capitalization of $208.04 billion, a PE ratio of 93.90, a P/E/G ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Equities research analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on ISRG shares. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Mizuho lifted their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a research report on Friday, October 18th. Citigroup increased their price target on Intuitive Surgical from $567.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. Finally, Stifel Nicolaus lifted their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.